The effect of birch pollen immunotherapy on hazelnut allergy.

Completed

• Conditions: Pollen/hazelnut allergy; Respiratory; Vasomotor and allergic rhinitis

• Registration Number: ISRCTN52709516
• Lead Sponsor: niversity Medical Centre Utrecht (UMCU) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

Patients greater than 18 years with birch pollen allergy and hazelnut allergy

Exclusion Criteria

1. Pregnancy
2. Significant concurrent disease
3. Instable asthma and oral medication with corticosteroids or beta-blocking agents

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DBPCFC with hazelnut before immunotherapy with birch pollen and after 1 year.

Secondary Outcome Measures

Name	Time	Method
1. Skin prick tests<br>2. Serological analyses